Latest News - McKesson
Top Corporates Hub
McKesson
Option Care Health (OPCH) Stock May Be Undervalued Despite The $5.8 Billion Buyout
09.10.2026 09:19
Option Care Health shares have jumped into focus after a sharp move higher and a US$5.8b buyout agreement, which raises a straightforward question for investors who care about valuation. Does the current price around the deal level make sense when you line it up against the earnings the business is generating? The stock gained 37.5% over the past week, which puts fresh pressure on the question of whether that surge is matched by the company’s earnings power. The agreed US$32.05 per share...
What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal?
07.10.2026 14:10
McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to acquire Option Care Health in a US$5.8b transaction announced in 2026. The deal structure gives McKesson a significant minority stake in Option Care Health alongside private equity ownership. The acquisition expands McKesson's reach in specialty care, including home and outpatient medical infusion services outside traditional hospital settings. The Option Care Health acquisition and McKesson's new minority stake sit against a wider...
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
07.10.2026 12:00
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?
07.10.2026 10:58
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Hadrian Raises $40M to Tackle the AI Hacking Cyber Security Crisis
06.10.2026 07:00
AMSTERDAM, October 06, 2026--Hadrian, the agentic AI offensive security platform, today announced a $40 million funding round co-led by Forgepoint Capital International and SmartFin, with participation from existing investors HV Capital, Motive Partners, Picus Capital and Oetker Ventures. The backing brings total funding to $65M and will fund expansion across EMEA and the U.S. and deepen investment in Hadrian's engineering and research teams.
Nvidia Generates $7.2 Million per Employee, Up 500% in 3 Years. This Number Is Even More Astounding.
05.10.2026 15:51
One Number: $7.2 Million in Revenue Per Employee NVIDIA (NASDAQ:NVDA) now brings in about $7.2 million in revenue for each person on its payroll. That figure comes from $302.97 billion in trailing 12-month revenue across roughly 42,000 employees, and it is 5.8x higher than it was three years ago. The revenue figure gets the attention, […]
New 2026 Cell and Gene Therapy Report Charts the Path from Scientific Progress to Patient Access
05.10.2026 11:00
IRVING, Texas, October 05, 2026--InspiroGene™ by McKesson today announced the publication of its third annual 2026 Cell and Gene Therapy Report.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
23.09.2026 13:00
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date
23.09.2026 12:00
IRVING, Texas, September 23, 2026--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
17.09.2026 10:10
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Did McKesson’s (MCK) EPS Hike and Oncology Push Just Redefine Its Investment Narrative?
15.09.2026 09:11
McKesson recently raised its full-year EPS guidance, projecting approximately 13%–15% growth (15%–17% excluding certain prior-year items), and outlined plans to rebrand its Medical-Surgical unit as Wellverse with a potential IPO targeted for the second half of 2027, alongside a pending acquisition of Precision Medicine Group to expand oncology and biopharma-services capabilities, subject to regulatory approval. This combination of upgraded earnings expectations, portfolio reshaping around...
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
14.09.2026 11:03
Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
09.09.2026 13:00
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Frazier Healthcare Partners Welcomes Tom Rodgers as Senior Partner
09.09.2026 12:00
SEATTLE, September 09, 2026--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Tom Rodgers will join the firm as a Senior Partner in October 2026. In this role, Mr. Rodgers will partner with Frazier’s Growth Buyout deal teams, providing strategic counsel on investment evaluation, portfolio value creation, and sector-level insights informed by more than 35 years of experience in healthcare strategy, corporate development
Underestimating The Moat: Why McKesson's Oncology Pivot And Share Buybacks Signal Structural Upside
08.09.2026 02:08
McKesson operates within a US pharma distribution oligopoly, generating $5B+ in FCF and aggressively repurchasing shares. See why I rate MCK stock a Buy.
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
04.09.2026 18:50
AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report?
04.09.2026 15:30
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
McKesson Stock: Is MCK Outperforming the Healthcare Sector?
04.09.2026 12:43
McKesson has outpaced the healthcare sector, and analysts remain highly optimistic about the stock’s outlook.
A Congress Member Sold Up To $15K In Viasat Stock: Here's What You Need To Know
04.09.2026 11:00
A September filing shows that Representative Jonathan Jackson reported a sale in Viasat (NASDAQ:VSAT), valued between $1,001 and $15,000. The transaction date is listed as August 28, 2026, with the report published on